Back to Results
First PageMeta Content
Medicine / Intellectual property law / Essential medicines / Pharmaceutical industry / Health care / Patent / IFPMA / Campaign for Access to Essential Medicines / Neglected tropical disease research and development / Pharmaceutical sciences / Pharmacy / Health


Workshop on Differential Pricing and Financing of Essential Drugs World Health Organization and World Trade Organization 8-11 April 2001 Høsbjør, Norway Session I: Access to Essential Drugs in Poor Countries -- Key Is
Add to Reading List

Document Date: 2001-06-18 18:00:00

Open Document

File Size: 21,95 KB

Share Result on Facebook

City

Geneva / Oslo / /

Company

Bristol Myers Squibb / /

Continent

Europe / /

Country

Norway / United States / Korea / China / Argentina / South Africa / India / /

Currency

USD / /

IndustryTerm

chemical applications / biotechnology research / research-based pharmaceutical industry / pharmaceutical industry / biotechnology industry / AIDS therapies / pharmaceutical products / pharmaceutical / manufacturing sectors / insurance schemes / accessible new technologies / /

MedicalCondition

TB / currently intractable disease / river blindness / targeted diseases / diseases / AIDS / infectious diseases / HIV/AIDS / infectious and non-infectious diseases / leprosy / /

Organization

Industry Perspective Harvey E. Bale Director General International Federation of Pharmaceutical Manufacturers Associations / World Health Organization / United Nations / Norwegian government / World Trade Organization / UNAIDS / OECD / /

Person

Abraham Lincoln / Amir Attiran / Annan / Jeffrey Sachs / /

Position

small company model of investment / Secretary General / Director-General / /

Product

penicillin / nevirapine / /

Technology

biotechnology / Human Genome / /

SocialTag